FindTrial
Sign In

A double-blind, randomized, placebo-controlled study of early oseltamivir treatment of influenza in children 1-3 years of age

A double-blind, randomized, placebo-controlled study of early oseltamivir treatment of influenza in children 1-3 years of age

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-004734-17-FI
Enrollment
Unknown
Registered
2007-09-19
Start date
2007-10-30
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza MedDRA version: 9.1 Level: LLT Classification code 10022000 Term: Influenza

Interventions

Trade Name: Tamiflu Pharmaceutical Form: INN or Proposed INN: oseltamivir phosphate Other descriptive name: OSELTAMIVIR PHOSPHATE Pharmaceutical form of the placebo: Oral suspension Route of administ

Sponsors

Terho Heikkinen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Secondary Objective: ;Primary end point(s): ;Main Objective:—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026